WARNINGDANGER OF DEATH
High doses alone or ordinary doses in combination with other depressants can fatally stop breathing.
Fentanyl
Fentanyl is a synthetic opioid1 of the anilidopiperidine class first synthesized by Paul Janssen in 19602 and approved for medical use in the United States in 19682. It is approximately 50 to 100 times more potent than morphine1 and is used clinically for breakthrough cancer pain and intraoperative analgesia2. Fentanyl is widely encountered as an adulterant in illicit drug supplies, particularly heroin, though also as an adulterant in other substances like cocaine and methamphetamine1, where its extreme potency has contributed to numerous accidental overdoses and fatalities1.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Due to the compound's extreme potency, accurate measurement is critical and the margin for error is very narrow. The risk of fatal overdose is high, particularly from respiratory depression. Individuals without opioid tolerance should use substantially lower starting amounts.
Duration
Subjective Effects
Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.
Effects vary widely by individual, dose, and context.
Physical
Cognitive
Pharmacology
Pharmacodynamics
Fentanyl activates the μ-opioid, δ-opioid and κ-opioid receptors, though with considerably lower affinity and relatively modest functional contribution at the latter two sites.8 μ-opioid receptor activation triggers G-protein-coupled signaling that inhibits neuronal activity through decreased cAMP production and altered ion conductance.9 Its exceptionally high lipid solubility enables rapid penetration of the central nervous system and may play part in its potency.10
Pharmacokinetics
Fentanyl undergoes extensive first-pass metabolism when taken orally, predominantly via CYP3A4-catalyzed N-dealkylation to norfentanyl, which accounts for approximately 99% of its biotransformation.1112 Minor pathways include amide hydrolysis and alkyl hydroxylation.12 All known metabolites are pharmacologically inactive.13 Fentanyl is 80 to 85% bound to plasma proteins and fentanyl does not bind to plasma cells, mostly binding to α-1-acid glycoprotein but also attaches to albumin and lipoproteins.1314 with a terminal half-life of approximately 7 hours.1315 Within 72 hours, roughly 75% of a dose is excreted in urine (less than 7% unchanged) and 9% in feces.16 Formulation-specific plasma timing is not subjective effect duration. LAZANDA nasal spray has a median Tmax of 15 to 21 minutes after a single dose,4 and SUBSYS sublingual spray has a median Tmax of 0.67 to 1.25 hours.5 Transdermal-system concentrations generally level off between 12 and 24 hours for the remainder of the 72-hour application period.7
Dangerous
Highest riskThese combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
Unsafe
AvoidThere is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
Caution
Use cautionThese combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Tolerance
Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.
All other opioids
Harm Potential
Addiction & Dependence
Psychological
Extremely HighFentanyl is considered extremely addictive with a high potential for abuse.1718
Physical
Extremely HighPhysical dependence develops with regular use.17 Withdrawal symptoms are severe and include diarrhea, nausea, sleep disorders, photophobia, autonomic hyperactivity runny nose, yawning and goosebumps.19
Toxicity
The primary acute danger is respiratory depression, which at overdose levels can cause anoxia, respiratory arrest, and death; this risk is substantially heightened in opioid-naive individuals and when combined with other CNS depressants.citation needed Wooden chest syndrome, a sudden rigidity of abdominal muscles and diaphragm causing complete respiratory failure, can occur with high doses.
Acute cardiovascular effects including vasodilation occur during intoxication; this is generally not associated with long-term cardiac damage at appropriate doses and do not significantly affect cardiac contractility at regular doses.citation needed
Constipation is one of the few long-term complications associated with appropriate fentanyl use; tolerance to this effect develops particularly slowly compared to other opioid effects.citation needed
Psychosis Risk
Hallucinations, delirium (including narcotic delirium), and confusion have been reported as adverse effects.1520 Post-acute withdrawal may include psychosis in extreme cases. These effects are relatively uncommon during typical use and are more associated with high doses, overdose, or withdrawal states.
Seizure Risk
Seizures are documented as a severe withdrawal symptom following chronic use and abrupt discontinuation, rather than as a direct effect of fentanyl intoxication.20 Withdrawal should be conducted gradually under medical supervision to minimize seizure risk.
History & Culture
Discovery and Synthesis
Fentanyl was first synthesized in 1959 by Belgian scientist Paul Janssen at Janssen Pharmaceutica, his relatively newly established pharmaceutical company.citation needed The compound was developed through systematic screening of chemical analogues of pethidine (marketed as Demerol) for enhanced…
Legality
International
Fentanyl is a narcotic drug in Schedule I of the 1961 Single Convention as amended. It is not listed as a psychotropic substance in the 1971 Convention schedules and is not a listed precursor chemical in the 1988 Convention Tables I or II.
By Country
References
Source Pages
Citations
- Fentanyl. Centers for Disease Control and Prevention (2025-06-09). https://www.cdc.gov/overdose-prevention/about/fentanyl.html1234
- Theodore H. Stanley. (2014). The Fentanyl Story. The Journal of Pain, 15(12), 1215-1226. https://doi.org/10.1016/j.jpain.2014.08.010123
- PsychonautWiki. psychonautwiki.org (n.d.). https://psychonautwiki.org/wiki/Fentanyl/Summary123
- LAZANDA (fentanyl) nasal spray, US prescribing information. dailymed.nlm.nih.gov (n.d.). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=73f38bde-2132-2b5a-e053-2a91aa0a6efb12
- SUBSYS (fentanyl sublingual spray), US prescribing information. dailymed.nlm.nih.gov (n.d.). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18a413e9-11e0-4a8f-86c0-d33b37b7b771123
- TripSit Wiki. wiki.tripsit.me (n.d.). https://wiki.tripsit.me/wiki/Fentanyl1
- Fentanyl Transdermal System, US prescribing information. dailymed.nlm.nih.gov (n.d.). https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b12fc2d1-555b-4a44-87f6-a2421324b2de12
- Donna A. Volpe, Grainne A. McMahon Tobin, R. Daniel Mellon, Aspandiar G. Katki, Robert J. Parker, Thomas Colatsky, Timothy J. Kropp, & S. Leigh Verbois. (2011). Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs. https://doi.org/10.1016/j.yrtph.2010.12.00712
- Dhaliwal A, Gupta M. Physiology, Opioid Receptor. (n.d.). https://www.ncbi.nlm.nih.gov/books/NBK546642/1
- Eamonn Kelly, Katy Sutcliffe, Damiana Cavallo, Nokomis Ramos‐Gonzalez, Norah Alhosan, & Graeme Henderson. (2021). The anomalous pharmacology of fentanyl. https://doi.org/10.1111/bph.155731
Further Reading
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass review
A first pass manual review and edit of article prose and copy has been performed by subject-matter expert Lyrea. This does not guarantee factual accuracy. An additional human review for each of this article's citations is yet to be performed.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Recent changes8 human edits · latest
Times are UTCNewest first
31 August 2026
Lyrea · Reworded 2 words in Harm Potential › Toxicity › Organ toxicity 2 › Findings
Lyrea · Reworded 2 words in Harm Potential › Toxicity › Organ toxicity 2 › Findings
Lyrea · Added a citation in Harm Potential › Toxicity › Organ toxicity 2 › Findings
Lyrea · Added a citation and removed a citation in Harm Potential › Toxicity › Organ toxicity 1 › Findings
Lyrea · Added a source: Fentanyl-Induced Chest Wall Rigidity
Lyrea · Reworded 14 words in Harm Potential › Toxicity › Organ toxicity 1 › Findings
Lyrea · Added a citation and removed a citation in Harm Potential › Toxicity › Organ toxicity 1 › Findings
Lyrea · Added a source: Fentanyl Citrate Injection — DailyMed prescribing information
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the Fentanyl article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.